Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

JCR. 2021; 8(2): 285-296


Prevalence and antimicrobial resistance properties of Extended-spectrum beta-lactamases (ESBL) producing Escherichia coli isolated from the cases of Urinary Tract Infections

Bahareh Tavakoli-Far, Fateme Pourhatami, Mohammad Javad Gharavi.

Abstract
Background and objectives: Extended-Spectrum Beta-Lactamase (ESBL) producing
Escherichia coli is the most prevalent cause of Urinary Tract Infections (UTIs). The present
research was done to study the prevalence and antibiotic resistance properties of ESBL and non-
ESBL producing Escherichia coli strains isolated from the cases of UTIs. Materials and
methods: Five-hundred and one urine samples were collected and cultured for E. coli. Positive
samples were analyzed for presence of ESBL. Antibiotic resistance pattern of strains was
analyzed using disk diffusion method. Results: Three-hundred and twenty-seven out of 501
(65.26%) urine specimens were positive for E. coli. Older than 40 years male (65.21%) and also
younger than 20 years female (96.77%) had the highest prevalence of E. coli. Prevalence of
ESBL and non-ESBL producing strains were 15.29% and 84.70%, respectively. ESBL E. coli
harbored the highest prevalence of resistance against ampicillin (100%), ceftriaxone (100%),
cefalexin (98%) and piperacillin (96%). Non-ESBL E. coli strains harbored the highest
prevalence of resistance against ciprofloxacin (76.89%), ampicillin (72.92%) and gentamicin
(68.95%). Conclusion: Imipenem, nitrofurantoin and tobramycin had good activity against both
ESBL and non-ESBL producing E. coli strains. Further researches are required to found other
epidemiological aspects of ESBL and non-ESBL producing E. coli strains isolated from UTIs.

Key words: Extended-Spectrum Beta-Lactamase, Escherichia coli, Antibiotic resistance, Urinary Tract Infections.



Similar Articles

Current Concepts in Prophylactic Antibiotics in Oral and Maxillofacial Surgery.
Dammling C, Abramowicz S, Kinard B
Oral and maxillofacial surgery clinics of North America. 2022; 34(1): 157-167

Synthesis of enhanced corrosion resistant Fe-B-C-Ti amorphous ribbons and evaluation of their photodegradation efficiency under light irradiation.
Zuo M, Moztahida M, Lee DS, Yi S
Chemosphere. 2022; 287(Pt 2): 132175

Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
Tak E, Kim M, Cho Y, Choi S, Kim J, Han B, Kim HD, Jang CS, Kim JE, Hong YS, Kim SY, Kim TW
Oncology reports. 2022; 47(1):

Geographic distribution and time trend of human exposure of Di(2-ethylhexyl) phthalate among different age groups based on global biomonitoring data.
Qu J, Xia W, Qian X, Wu Y, Li J, Wen S, Xu S
Chemosphere. 2022; 287(Pt 2): 132115

Enhancing the flame retardancy and UV resistance of polyamide 6 by introducing ternary supramolecular aggregates.
Li Y, Wang J, Xue B, Wang S, Qi P, Sun J, Li H, Gu X, Zhang S
Chemosphere. 2022; 287(Pt 2): 132100


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites